Contact BioSolutions raises $8.1 million AUD to expand FireHawk bioherbicide

Contact BioSolutions has raised $8.1 million AUD through an options conversion with participation above 98%, giving the FireHawk maker fresh capital to expand in Australia and the U.S. The funding follows regulatory wins, including APVMA approval in Australia and EPA registration in all 50 U.S. states for FireHawk’s RTU product.

Why it matters: - Contact BioSolutions secured fresh capital to accelerate FireHawk Bioherbicide’s expansion in two major markets. - The raise comes as the company pushes toward profitability and broader adoption in regenerative agriculture and sustainable weed management. - FireHawk’s regulatory progress lowers barriers to commercial use in Australia and the U.S.

What happened: - Contact BioSolutions completed an $8.1 million AUD capital raise, equal to about $5.6 million USD. - The funding came through conversion of options. - Participation exceeded 98%. - Dr. Frank Glatz, Managing Director at Contact BioSolutions, said the capital gives the company a strong basis to support its next phase of growth.

The details: - FireHawk Bioherbicide Super Concentrate recently received approval from the Australian Pesticides and Veterinary Medicines Authority. - FireHawk’s Ready-to-Use and Super Concentrate products have been certified for use in organic and regenerative systems through Southern Cross Certification, Cert. No. 24001. - FireHawk Super Concentrate is slated for launch across Australia soon. - In the U.S., FireHawk’s RTU product is EPA-registered in all 50 states. - FireHawk Super Concentrate is registered in 48 states. - The company expects CDPR approval to register the Super Concentrate product in California this fall. - Contact BioSolutions also secured a $25,000 order from a regenerative farm in Texas. - FireHawk uses nonanoic acid with patented delivery technology to control weeds, grasses, moss and algae without residual soil activity. - FireHawk begins working on contact and shows visible results in as few as 1-3 hours. - FireHawk Super Concentrate contains 85.26% nonanoic acid. - The product is designed for commercial, industrial and agricultural settings, subject to local label approvals and regulations.

Between the lines: - The high option-conversion participation signals investor confidence at a time when startup funding remains tight. - Regulatory approvals and organic certification position FireHawk for use cases where buyers want alternatives to conventional herbicides. - The Texas order is small, but it adds a revenue signal and suggests early traction in regenerative agriculture. - Contact BioSolutions is trying to turn product validation into scale before rivals gain ground in the same niche.

What's next: - FireHawk Super Concentrate is expected to launch in Australia soon. - The company is waiting on California registration for the U.S. Super Concentrate product this fall. - Contact BioSolutions plans to use the new capital to expand operations and advance toward profitability. - The company will continue growing across Australia and the United States as adoption builds.